Medical Marijuana For Rheumatoid Arthritis: What Your Doctor Isn’t Telling You

Some rheumatoid arthritis patients say that using forms of medical marijuana eases the pain and inflammation they suffer from their condition. Yet most doctors specializing in rheumatoid arthritis treatment were unaware that a growing body of research identifies medical marijuana’s active ingredient, cannabinoids, as a possible arthritis treatment, according to a 2014 survey in the […]

Read More

Impact Of Legalized Medical Marijuana In Colombia

Colombia is among a growing list of countries that have legalized marijuana for medical use. While many applaud the development, this sanctioning also brings new regulations, bureaucracy and costs. Little Valeria Rincon was diagnosed with epilepsy when she was just a few months old. Early on, she did not respond well to traditional drug treatment. […]

Read More

Opioid Overdose Rate Drops In Medical Marijuana States

Medical marijuana may serve as a non-fatal alternative to prescription opioids when it comes to chronic pain management, according to some health experts. In a New York Times opinion piece, medical researcher Colleen Barry posits that while the rise in opioid prescriptions has mirrored the expansion of medical marijuana laws, only states with such laws […]

Read More

DEA Approves PTSD Marijuana Study

The Drug Enforcement Agency has given its blessing to a study on the effect of medical marijuana on post-traumatic stress disorder, the first randomized, controlled research in the U.S. for PTSD that will use the actual plant instead of oils or synthesized cannabis. According to the research’s nonprofit sponsor, Multidisciplinary Association for Psychedelic Studies, or […]

Read More

The Science Behind The DEA’s Long War On Marijuana

Experts say listing cannabis among the world’s deadliest drugs ignores decades of scientific and medical data. But attempts to delist it have met with decades of bureaucratic inertia and political distortion. Speculation is growing about the possibility that the U.S. Drug Enforcement Administration (DEA) will review by summer its “Schedule I” designation of marijuana as […]

Read More